516 related articles for article (PubMed ID: 17143333)
1. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP.
Krishnamurthy B; Dudek NL; McKenzie MD; Purcell AW; Brooks AG; Gellert S; Colman PG; Harrison LC; Lew AM; Thomas HE; Kay TW
J Clin Invest; 2006 Dec; 116(12):3258-65. PubMed ID: 17143333
[TBL] [Abstract][Full Text] [Related]
2. Proinsulin: a unique autoantigen triggering autoimmune diabetes.
You S; Chatenoud L
J Clin Invest; 2006 Dec; 116(12):3108-10. PubMed ID: 17143326
[TBL] [Abstract][Full Text] [Related]
3. Human clonal CD8 autoreactivity to an IGRP islet epitope shared between mice and men.
Unger WW; Pinkse GG; Mulder-van der Kracht S; van der Slik AR; Kester MG; Ossendorp F; Drijfhout JW; Serreze DV; Roep BO
Ann N Y Acad Sci; 2007 Apr; 1103():192-5. PubMed ID: 17376840
[TBL] [Abstract][Full Text] [Related]
4. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes.
Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV
J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087
[TBL] [Abstract][Full Text] [Related]
5. Regulatory CD8+ T cells induced by exposure to all-trans retinoic acid and TGF-beta suppress autoimmune diabetes.
Kishi M; Yasuda H; Abe Y; Sasaki H; Shimizu M; Arai T; Okumachi Y; Moriyama H; Hara K; Yokono K; Nagata M
Biochem Biophys Res Commun; 2010 Mar; 394(1):228-32. PubMed ID: 20206130
[TBL] [Abstract][Full Text] [Related]
6. Identification of CD4+ T cell-specific epitopes of islet-specific glucose-6-phosphatase catalytic subunit-related protein: a novel beta cell autoantigen in type 1 diabetes.
Mukherjee R; Wagar D; Stephens TA; Lee-Chan E; Singh B
J Immunol; 2005 May; 174(9):5306-15. PubMed ID: 15843527
[TBL] [Abstract][Full Text] [Related]
7. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
8. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice.
Pang S; Zhang L; Wang H; Yi Z; Li L; Gao L; Zhao J; Tisch R; Katz JD; Wang B
Eur J Immunol; 2009 Oct; 39(10):2716-24. PubMed ID: 19658094
[TBL] [Abstract][Full Text] [Related]
9. Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes.
Han B; Serra P; Yamanouchi J; Amrani A; Elliott JF; Dickie P; Dilorenzo TP; Santamaria P
J Clin Invest; 2005 Jul; 115(7):1879-87. PubMed ID: 15937548
[TBL] [Abstract][Full Text] [Related]
10. Minimal impact of a de novo-expressed beta-cell autoantigen on spontaneous diabetes development in NOD mice.
Martinic MM; Juedes AE; Bresson D; Homann D; Skak K; Huber C; Ling E; Ejrnaes M; Wolfe T; Togher L; Christen U; von Herrath MG
Diabetes; 2007 Apr; 56(4):1059-68. PubMed ID: 17395746
[TBL] [Abstract][Full Text] [Related]
11. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
[TBL] [Abstract][Full Text] [Related]
12. Autoantigen recognition is required for recruitment of IGRP(206-214)-autoreactive CD8+ T cells but is dispensable for tolerance.
Wang J; Tsai S; Han B; Tailor P; Santamaria P
J Immunol; 2012 Sep; 189(6):2975-84. PubMed ID: 22908330
[TBL] [Abstract][Full Text] [Related]
13. Genetic and therapeutic control of diabetogenic CD8+ T cells.
Santamaria P
Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463
[TBL] [Abstract][Full Text] [Related]
14. Autoimmunity to both proinsulin and IGRP is required for diabetes in nonobese diabetic 8.3 TCR transgenic mice.
Krishnamurthy B; Mariana L; Gellert SA; Colman PG; Harrison LC; Lew AM; Santamaria P; Thomas HE; Kay TW
J Immunol; 2008 Apr; 180(7):4458-64. PubMed ID: 18354167
[TBL] [Abstract][Full Text] [Related]
15. Long-range enhancers are required to maintain expression of the autoantigen islet-specific glucose-6-phosphatase catalytic subunit-related protein in adult mouse islets in vivo.
Wang Y; Flemming BP; Martin CC; Allen SR; Walters J; Oeser JK; Hutton JC; O'Brien RM
Diabetes; 2008 Jan; 57(1):133-41. PubMed ID: 17942825
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous autoimmunity sufficiently potent to induce diabetes mellitus is insufficient to protect against insulinoma.
Zwicker K; Chatten C; Gratton K; Demetrick D; Serra P; Shameli A; Santamaria P; Bathe OF
J Immunol; 2009 Aug; 183(3):1705-14. PubMed ID: 19570832
[TBL] [Abstract][Full Text] [Related]
17. Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide.
Han B; Serra P; Amrani A; Yamanouchi J; Marée AF; Edelstein-Keshet L; Santamaria P
Nat Med; 2005 Jun; 11(6):645-52. PubMed ID: 15908957
[TBL] [Abstract][Full Text] [Related]
18. beta cell-specific CD4+ T cell clonotypes in peripheral blood and the pancreatic islets are distinct.
Li L; He Q; Garland A; Yi Z; Aybar LT; Kepler TB; Frelinger JA; Wang B; Tisch R
J Immunol; 2009 Dec; 183(11):7585-91. PubMed ID: 19917704
[TBL] [Abstract][Full Text] [Related]
19. A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes.
Hutton JC; Eisenbarth GS
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8626-8. PubMed ID: 12861077
[No Abstract] [Full Text] [Related]
20. Adult-onset type 1 diabetes patients display decreased IGRP-specific Tr1 cells in blood.
Chujo D; Nguyen TS; Foucat E; Blankenship D; Banchereau J; Nepom GT; Chaussabel D; Ueno H
Clin Immunol; 2015 Dec; 161(2):270-7. PubMed ID: 26341315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
